PharmX Technologies Limited PHX
ASX · Australia · Technology Services
AUD 0.09600.00 (0.00%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
As the Australian market approaches the holiday season, it seems to be winding down with a slight dip, likely due to profit-taking activities as major indices overseas flirt with record highs. For investors looking beyond the well-trodden paths of large-cap stocks, penny stocks—despite their somewhat old-fashioned moniker—remain a fascinating area of exploration. These smaller or newer companies can offer unique opportunities for those willing to explore their potential, often combining value...
PharmX has the economics of a monopoly -- but not yet the cash flow of one.
The Australian market has been navigating a cautious phase, with ASX futures reflecting a slight downturn amid broader concerns over recent economic data and global financial conditions. In such times, investors often look beyond the established giants to explore opportunities in lesser-known corners of the market. Penny stocks, though an outdated term, continue to represent intriguing possibilities for growth and diversification by focusing on smaller or newer companies that may offer strong...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.